COVID-19 has accelerated changes that were already coming to the biotechnology sales and marketing space, most notably the shift towards digital platforms. Smart companies have stayed ahead of the game by taking advantage of digital sales enablement strategies and tools such as marketing automation, and customer relationship management systems. In this podcast, we spoke with two biotechnology marketing veterans – Alan Findlater, Chief Commercial Officer at BioIVT, and Jeremiah Worth, Vice President of Digital Marketing at CG Life – about their insights on how sales and marketing teams can best work together in this new and (perhaps surprisingly) promising landscape.